Remote Peritoneal Dialysis Support Platforms: Innovations, Clinical Impact, and Future Directions

Abstract

Remote peritoneal dialysis (PD) support platforms represent a transformative advancement in nephrology, offering patients and clinicians enhanced connectivity, monitoring, and management opportunities. This review explores the scientific foundations, clinical efficacy, and practical implications of remote PD support systems, integrating evidence from recent studies and guideline recommendations. Emphasis is placed on the epidemiological need, underlying mechanisms, risk stratification, diagnostic considerations, management strategies, and the clinical outcomes associated with these platforms, as well as their emerging role in contemporary renal care.

Introduction

Peritoneal dialysis is a life-sustaining modality for patients with end-stage kidney disease (ESKD), providing renal replacement therapy outside the traditional in-center hemodialysis setting. Remote PD support platforms have emerged as a response to the growing demand for patient autonomy, real-time monitoring, and optimized healthcare resource utilization. By leveraging digital health, telemedicine, and advanced informatics, these systems allow healthcare professionals to monitor PD patients remotely, intervene proactively, and potentially improve outcomes. This review aims to provide a comprehensive and clinically relevant synthesis of the current landscape and future directions of remote PD support platforms, focusing on evidence-based insights and practical implications for the nephrology community.

Epidemiology / Disease Burden

The global prevalence of ESKD is increasing steadily, with millions requiring renal replacement therapy. According to the United States Renal Data System (USRDS) and international registries, PD accounts for approximately 11-15% of all dialysis modalities, though utilization rates vary by region due to resource availability and patient selection. The COVID-19 pandemic underscored the vulnerability of in-center hemodialysis populations and highlighted the need for out-of-facility solutions such as PD. Despite its advantages, PD is underutilized, partly due to concerns regarding complications, patient self-management capacity, and access to expert support. Remote support platforms have the potential to bridge these gaps, aligning with the increasing burden of chronic kidney disease (CKD) and the imperative for scalable, cost-effective renal care delivery models.

Pathophysiology

PD utilizes the patient's peritoneal membrane as a semipermeable barrier to facilitate solute exchange and ultrafiltration. The effectiveness and safety of PD depend on the peritoneal membrane characteristics, dialysate composition, and patient adherence to prescribed exchanges. Disruptions in technique, infection, or ultrafiltration failure can compromise outcomes. Remote support platforms enable the continuous capture of key physiological parameters such as dwell times, ultrafiltration volumes, and exchange quality through connected cyclers and wearable sensors. These data streams can be analyzed in real time, enabling clinicians to detect early deviations from optimal therapy and intervene before clinical deterioration occurs.

Risk Factors

Risk factors influencing PD outcomes include patient age, comorbidity burden (notably diabetes and cardiovascular disease), malnutrition, prior abdominal surgeries, and socioeconomic barriers. Inadequate training, cognitive impairment, and lack of social support may predispose patients to technique failure and complications. Remote support platforms can mitigate some of these risks by providing continuous education, reminders, and direct communication channels between patients and care teams. Machine learning algorithms can further stratify risk based on data patterns, facilitating personalized care plans and targeted interventions.

Clinical Features

PD patients are at risk for complications such as peritonitis, exit-site infections, ultrafiltration failure, and volume overload. Early clinical features may be subtle, including changes in dialysate clarity, abdominal pain, or weight fluctuations. Remote monitoring enables the timely detection of such features through patient-reported outcomes, device data uploads, and automated alerts. For example, a sudden drop in ultrafiltration volume or a documented fever can trigger immediate contact with the care team, expediting diagnostic workup and management. This proactive approach has been shown to reduce hospitalizations and technique failure rates.

Diagnosis

The diagnosis of PD-related complications often relies on a combination of clinical assessment, laboratory analysis (dialysate cell counts, cultures), and imaging when indicated. Remote support platforms facilitate early recognition through symptom tracking, automated trend analysis, and integration with electronic health records. Algorithms can flag deviations from normative data, prompting clinicians to initiate diagnostic protocols remotely. This approach can streamline care pathways, reduce unnecessary clinic visits, and ensure timely intervention, especially for patients in remote or underserved areas.

Treatment & Management

Effective PD management requires individualized prescription adjustments, timely management of complications, and ongoing patient education. Remote platforms support dynamic prescription modification based on real-time data, enable rapid troubleshooting of technical issues, and offer teleconsultations for clinical decision-making. Interventions such as remote training sessions, digital adherence support, and virtual multidisciplinary rounds have demonstrated efficacy in maintaining technique survival and reducing peritonitis rates. The integration of remote support into standard care pathways is associated with improved patient satisfaction, reduced travel burden, and optimized resource allocation.

Recent Advances / Emerging Therapies

Recent years have seen the proliferation of advanced remote PD support technologies, including cloud-based data aggregation, artificial intelligence-driven analytics, and automated alert systems. Connected cyclers now transmit real-time data directly to care teams, while mobile applications empower patients to self-monitor and communicate issues promptly. Emerging therapies include wearable biosensors capable of monitoring vital signs, hydration status, and even biochemical markers, paving the way for more granular and predictive patient management. Pilot studies and randomized controlled trials have reported reductions in hospitalization rates, enhanced clinical outcomes, and improved patient-reported quality of life through remote support integration.

Guideline Recommendations

International nephrology guidelines, including those from the International Society for Peritoneal Dialysis (ISPD) and Kidney Disease: Improving Global Outcomes (KDIGO), now recognize the utility of telemedicine and remote monitoring in PD care. Recommendations emphasize the importance of infrastructure for secure data transmission, patient privacy safeguards, and the need for tailored patient education. Guideline committees highlight that remote support should augment rather than replace traditional clinical care, and that its implementation must consider resource constraints, patient preferences, and regulatory frameworks. Ongoing research is encouraged to further define best practices and assess long-term cost-effectiveness.

Conclusion

Remote peritoneal dialysis support platforms represent a pivotal innovation in the field of nephrology, aligning technological progress with the evolving needs of patients and healthcare systems. By enabling proactive monitoring, data-driven decision-making, and enhanced patient engagement, these platforms have the potential to improve clinical outcomes, reduce complications, and expand access to home-based dialysis. Continued research, guideline refinement, and investment in digital infrastructure will be essential to fully realize the benefits of remote PD support and to ensure that these advances translate into tangible improvements in global kidney care.